Shapiro R, Ruiz-Gutierrez M, Chen C Z
Center for Biochemical and Biophysical Sciences and Medicine, Harvard Medical School, Boston, MA 02115, USA.
J Mol Biol. 2000 Sep 15;302(2):497-519. doi: 10.1006/jmbi.2000.4075.
Ribonuclease inhibitor (RI) binds diverse mammalian RNases with extraordinary avidity. Here, we have investigated the structural basis for this tight binding and broad specificity by mutational analysis of the complexes of RI with angiogenin (Ang) and RNase A (K(D)=0.5 fM and 43 fM, respectively). Both crystal structures are known; the interfaces are large, and the ligands dock similarly, although few of the specific interactions formed are analogous. Our previous mutagenesis studies focused primarily on one contact region, containing RI 434-438 and the enzymatic active site. Many single-residue replacements produced extensive losses of binding energy (2.3-5.9 kcal/mol), suggesting that this region constitutes a "hot spot" in both cases. We have now explored the roles of most of the remaining RI residues that interact with Ang and/or RNase A. One major cluster in each complex lies in a Trp-rich area of RI, containing Trp261, Trp263, Trp318, and Trp375. Although the energy losses from individual replacements in this portion of the Ang complex were small-to-moderate (0-1.5 kcal/mol), the changes from multiple substitutions were much greater than additive, and the binding energy provided by this region is estimated to be approximately 6 kcal/mol (30 % of total). Effects of replacing combinations of hot spot components had also been found to be superadditive, and this negative cooperativity is now shown to extend to the neighboring contact residue RI Ser460. The overall contribution of the hot spot, taking superadditivity into account, is then approximately 14-15 kcal/mol. The hot spot and Trp-rich regions, although spatially well separated, are themselves functionally linked. No other parts of the RI-Ang interface appear to be energetically important. Binding of RNase A is more sensitive to substitutions throughout the interface, with free energy losses>/=1 kcal/mol produced by nearly all replacements examined, so that the sum of losses greatly exceeds the binding energy of the complex. This discrepancy can be explained, in part, by positive cooperativity, as evident from the subadditive effects observed when combinations of residues in either the hot spot or Trp-rich region are replaced. These findings suggest that the binding energy may be more widely distributed in the RNase A complex than in the Ang complex.
核糖核酸酶抑制剂(RI)能以极高的亲和力结合多种哺乳动物核糖核酸酶。在此,我们通过对RI与血管生成素(Ang)和核糖核酸酶A(K(D)分别为0.5 fM和43 fM)复合物的突变分析,研究了这种紧密结合和广泛特异性的结构基础。两种复合物的晶体结构均已知;尽管形成的特定相互作用很少相似,但界面较大,且配体的对接方式类似。我们之前的诱变研究主要集中在一个接触区域,该区域包含RI 434 - 438和酶活性位点。许多单残基替换导致结合能大幅损失(2.3 - 5.9千卡/摩尔),这表明该区域在两种情况下均构成一个“热点”。我们现在探究了与Ang和/或核糖核酸酶A相互作用的其余大多数RI残基的作用。每种复合物中的一个主要簇位于RI富含色氨酸的区域,包含Trp261、Trp263、Trp318和Trp375。尽管Ang复合物中该部分单个替换导致的能量损失较小至中等(0 - 1.5千卡/摩尔),但多个替换产生的变化远大于相加效应,该区域提供的结合能估计约为6千卡/摩尔(占总量的30%)。还发现替换热点成分组合的效应具有超加性,并且这种负协同性现在表明延伸至相邻的接触残基RI Ser460。考虑到超加性,热点的总体贡献约为14 - 15千卡/摩尔。热点和富含色氨酸的区域虽然在空间上相隔较远,但它们在功能上相互关联。RI - Ang界面的其他部分似乎在能量上并不重要。核糖核酸酶A的结合对整个界面的替换更敏感,几乎所有检测的替换都会产生≥1千卡/摩尔的自由能损失,因此损失总和大大超过复合物的结合能。这种差异部分可以通过正协同性来解释,这从热点或富含色氨酸区域的残基组合被替换时观察到的次加性效应中可以明显看出。这些发现表明,核糖核酸酶A复合物中的结合能可能比Ang复合物中的分布更广泛。